About Klotho Neurosciences, Inc. - Common Stock (KLTO)
Klotho Neurosciences, Inc. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. The company is dedicated to harnessing the therapeutic potential of Klotho, a protein that has been linked to cognitive function and resilience against age-related decline. By exploring the molecular mechanisms of Klotho, Klotho Neurosciences aims to create therapeutics that can modify disease progression and improve the quality of life for individuals affected by neurological disorders. Their pipeline includes research and development efforts aimed at addressing conditions such as Alzheimer's disease and other forms of neurodegeneration, positioning them at the forefront of advancements in neurotherapeutics. Read More
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical trials, and a waiver of the user fee for its ALS gene therapy.
Peraso Inc. (NASDAQ: PRSO) has secured its first production order for a 60GHz wireless video system designed for educational environments, marking a strategic expansion into the classroom connectivity market. The system enables low-latency, high-speed video streaming without overloading congested school Wi-Fi networks, using Peraso’s mmWave platform to deliver reliable performance in high-density settings.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Peraso Inc. (NASDAQ: PRSO) has endorsed the NTIA’s revised $42.45B BEAD program, now favoring technology-neutral broadband deployment. The change clears the way for Peraso’s mmWave FWA to deliver 2.5Gbps speeds—offering a cost-effective, fiber-like alternative for rural and underserved areas.
